Humana (HUM) Cost of Revenue (2009 - 2026)

Humana (HUM) has 18 years of Cost of Revenue data on file, last reported at $33.7 billion in Q1 2026.

• On a quarterly basis, Cost of Revenue rose 27.03% year-over-year to $33.7 billion in Q1 2026; TTM through Mar 2026 was $118.0 billion, a 15.59% increase from a year earlier, with the FY2025 full-year figure at $110.8 billion, up 10.08% from the prior year.
• Cost of Revenue for Q1 2026 stood at $33.7 billion, up from $28.7 billion in the prior quarter.
• Over the last five years, Cost of Revenue for HUM reached as high as $33.7 billion in Q1 2026 and fell as low as $18.4 billion in Q3 2022.
• Historically, Cost of Revenue has averaged $24.1 billion across 5 years, with a median of $25.0 billion in 2024.
• Across the five-year window, Cost of Revenue grew 5.62% in 2025 and climbed 27.03% in 2026, its largest moves.
• Year by year, Cost of Revenue stood at $18.6 billion in 2022, then gained by 22.6% to $22.8 billion in 2023, then advanced by 11.41% to $25.4 billion in 2024, then rose by 13.16% to $28.7 billion in 2025, then gained by 17.36% to $33.7 billion in 2026.
• Per Business Quant data, the three most recent Cost of Revenue figures were $33.7 billion in Q1 2026, $28.7 billion in Q4 2025, and $28.0 billion in Q3 2025.